Sigma stock: Morgans keeps Buy rating for Sigma Healthcare stock at AUD 3.19

Published on 10/22/2026 at 19:48 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Sigma's network now exceeds 950 stores after its October 21 AGM. Sigma stock costs EUR 1.73 on October 22, 2026 at 7:39 p.m. CEST at Lang & Schwarz.

Analyst target and operating scale

Morgans maintained a Buy rating and set an AUD 3.19 target on October 21, 2026.
Sigma Healthcare reported a network of more than 950 stores at its October 21, 2026 AGM.
Sigma stock costs EUR 1.73 at Lang & Schwarz on October 22, 2026 at 7:39 p.m. CEST.

Sigma, AU000000SIG5, Illustration mit AI erstellt.

Sigma Healthcare (AU000000SIG5) received a maintained Buy rating and an AUD 3.19 price target from Morgans on October 21, 2026. The target is 16.42 percent above Sigma's AUD 2.74 home-market price at the October 22, 2026 close, while the euro quote stood at EUR 1.73 at Lang & Schwarz on October 22, 2026 at 7:39 p.m. CEST.

Target sits above the market

According to Markets Insider, Scott Power of Morgans maintained the Buy rating and set the AUD 3.19 target in a report dated October 21, 2026. The report did not provide an earlier target for comparison, so the key measure is the distance between the target and the AUD 2.74 market price.

That distance leaves 16.42 percent of potential upside from the home-market price to the target, calculated in Australian dollars. The comparison is useful because the Lang & Schwarz quote is in euros and cannot be combined with the Australian-dollar target in one return calculation.

950 stores define the scale

Sigma's annual general meeting on October 21, 2026 highlighted an operating network of more than 950 stores, including 561 Chemist Warehouse locations in Australia, according to Pharmacy Daily. The same report said international sales increased 23 percent during the reported year and that 20 new stores were added.

For investors, the store count provides the operating scale behind the analyst view. The reported update also identified softer discretionary demand in ladies fragrances, vitamins and supplements, creating a concrete counterpoint to the expansion figures.

Valuation remains a key marker

Sigma's market capitalization was AUD 31.5 billion as of October 22, 2026, with a price-to-earnings ratio of 44.48. The same market snapshot placed the 52-week range at AUD 2.47 to AUD 3.20, leaving the AUD 2.74 price 14.38 percent below the high and 10.93 percent above the low.

The current valuation therefore sits between the year's two recorded extremes, while Morgans' AUD 3.19 target is close to the upper end of that range. The next investor reference point is the company's operating execution across its expanded pharmacy network.

Stock price after the Xetra session

Sigma stock was trading at EUR 1.73 at Lang & Schwarz on October 22, 2026 at 7:39 p.m. CEST. The quote represents an after-hours indication for German investors and is separate from the Australian-dollar target and home-market price.

The further course of trading is shown by the continuously updated real-time quote of Sigma stock.